NPAS4 as A Promising Drug Target for PML (G266743)

Target Name: NPAS4

NCBI ID: G266743

NPAS4

NPAS4 as A Promising Drug Target for PML

The hematopoietic stem cell (HSC) is a diverse and powerful cell that has the ability to generate all of the different blood cells in the human body. These cells have the potential to regenerate and repair damaged tissue, making them an attractive target for drug development in various diseases. One promising candidate for drug targeting in the HSC is the neurogenic factor HeLa-Promyelocytic leukemia (PML), which is a transcription factor that plays a crucial role in the development and maintenance of HSC.

The Nuclear Protein-Activated Status (NPAS4) gene is a key regulator of PML. It encodes a protein that is involved in the transcription of PML gene. The NPAS4 gene is a promising drug target in PML because it is a known protein that can be targeted with small molecules.

The HHSCs have the ability to self-renew and differentiate into different cell types in the human body. These cells have the potential to regenerate and repair damaged tissue, making them an attractive target for drug development in various diseases, including PML.

The PML is a type of cancer that affects the blood cells. It is characterized by the uncontrolled proliferation of white blood cells in the bone marrow, leading to anemia, infections, and other serious health problems. PML is a serious and often fatal disease, and there is a high need for new treatments.

NPAS4 is a transcription factor that plays a crucial role in the development and maintenance of PML. It is a known protein that can be targeted with small molecules, making it a promising candidate for drug targeting in PML.

The mechanism of action of NPAS4

NPAS4 is a transmembrane protein that is located in the cytoplasm of the human cell. It is a key regulator of PML and is involved in the transcription of the PML gene. PML is a type of cancer that affects the blood cells, and it is characterized by the uncontrolled proliferation of white blood cells in the bone marrow.

NPAS4 is a transcription factor that plays a crucial role in the development and maintenance of PML. It is a known protein that can be targeted with small molecules, making it a promising candidate for drug targeting in PML.

The functions of NPAS4

NPAS4 is a transcription factor that is involved in the regulation of gene expression in the human cell. It is a key regulator of PML and is involved in the transcription of the PML gene. PML is a type of cancer that affects the blood cells, and it is characterized by the uncontrolled proliferation of white blood cells in the bone marrow.

NPAS4 is a transcription factor that plays a crucial role in the development and maintenance of PML. It is a known protein that can be targeted with small molecules, making it a promising candidate for drug targeting in PML.

The potential therapeutic benefits of NPAS4

The use of NPAS4 as a drug target in PML has the potential to treat this disease in a more effective and safe manner. By using small molecules to stimulate the activity of NPAS4, researchers may be able to inhibit its activity and reduce the number of PML cells in the bone marrow. This could lead to a reduction in the severity of PML symptoms and an improvement in the overall quality of life for patients.

In addition, NPAS4 may also be used to treat other diseases that are characterized by the uncontrolled proliferation of white blood cells, such as leukemia or myelodysplastic syndromes. By targeting the transcription factor with small molecules, researchers may be able to inhibit its activity and reduce the number of abnormal cells in the bone marrow.

Conclusion

In conclusion, NPAS4 is a transcription factor that plays a crucial role in the development and maintenance of PML. It is a known protein that can be targeted with small molecules, making it a promising candidate for drug targeting in PML. Studies have shown that NPAS4 may be a promising drug target for PML, with the potential to treat this disease in a more effective and safe manner. Further research is needed to fully understand the effects of NPAS4

Protein Name: Neuronal PAS Domain Protein 4

Functions: Transcription factor expressed in neurons of the brain that regulates the excitatory-inhibitory balance within neural circuits and is required for contextual memory in the hippocampus (By similarity). Plays a key role in the structural and functional plasticity of neurons (By similarity). Acts as an early-response transcription factor in both excitatory and inhibitory neurons, where it induces distinct but overlapping sets of late-response genes in these two types of neurons, allowing the synapses that form on inhibitory and excitatory neurons to be modified by neuronal activity in a manner specific to their function within a circuit, thereby facilitating appropriate circuit responses to sensory experience (By similarity). In excitatory neurons, activates transcription of BDNF, which in turn controls the number of GABA-releasing synapses that form on excitatory neurons, thereby promoting an increased number of inhibitory synapses on excitatory neurons (By similarity). In inhibitory neurons, regulates a distinct set of target genes that serve to increase excitatory input onto somatostatin neurons, probably resulting in enhanced feedback inhibition within cortical circuits (By similarity). The excitatory and inhibitory balance in neurons affects a number of processes, such as short-term and long-term memory, acquisition of experience, fear memory, response to stress and social behavior (By similarity). Acts as a regulator of dendritic spine development in olfactory bulb granule cells in a sensory-experience-dependent manner by regulating expression of MDM2 (By similarity). Efficient DNA binding requires dimerization with another bHLH protein, such as ARNT, ARNT2 or BMAL1 (PubMed:14701734). Can activate the CME (CNS midline enhancer) element (PubMed:14701734)

The "NPAS4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NPAS4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets